Presentation and attrition in complex pulmonary atresia  by Mee, Roger B.B.
JACC Vol. 28, No. 2 539 
August 1996:539 41 
LETTERS TO THE EDITOR 
Central Blood Volume: An Explanation of 
Racial Differences in Left Ventricular Mass? 
The intriguing study of Schmieder et al. (1) suggests a hypothesis 
regarding the extensively documented but unexplained excess preva- 
lence of left ventricular hypertrophy and hypertensive h art disease in 
African-American compared with European-American populations of
hypertensive and normotensive subjects (2). Schmieder et al. report 
findings consistent with the concept that increased central blood 
volume may be an important determinant of concomitantly increased 
left ventricular mass in borderline hypertension compared with nor- 
motension. In their study, heart rate and plasma renin were similar 
among groups. It was suggested that the central volume-dependent 
initial phase of essential hypertension may be followed by a chronic 
phase with normal central blood volume, increased total peripheral 
resistance and increased left ventricular mass. Many studies have 
reported a higher prevalence of low plasma renin levels, suggesting 
expanded intravascular volume in African-Americans compared with 
European-Americans, both among hypertensives and normotensive 
subjects (2-5). Racial differences in renal handling of sodium have 
been postulated to explain the higher prevalence ofvolume xpansion 
and hypertension (2-5). Furthermore, the prevalence of left ventricu- 
lar hypertrophy by echocardiography or electrocardiography and of 
hypertensive heart disease was increased out of proportion to the 
excess in hypertension prevalence or blood pressure level. This leads 
one to ask, Does a greater prevalence of expanded central blood 
volume in African-Americans explain, at least in part, the much higher 
prevalence of left ventricular hypertrophy, which persists after control- 
ling for blood pressure level? Schmieder et al. reported results of 
subgroup analyses by gender. In their study, did central blood volume 
and left ventricular mass differ by race? Could a racial difference in left 
ventricular mass be statistically explained by a difference in central 
blood volume with or without adjusting for age, gender, height, 
duration of hypertension, and blood pressure? Analyses of race in this 
and other biracial studies might shed light on the mechanism ofexcess 
left ventricular hypertrophy inAfrican-Americans. 
RICHARD F. GILLUM, MD, FACC 
Centers for Disease Control and Prevention 
Office of Analysis Epidemiolog¢ and Health Promotion 
National Center for Health Statistics 
6525 Belcrest Road 
Hyattsville, Maryland 20782 
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Reply 
The question of whether a greater prevalence of an expanded central 
blood volume in African-Americans than in whites could initiate 
cardiovascular structural adaptation and, thereby, explain the higher 
prevalence of left ventricular hypertrophy in this population isof great 
interest. As far as we can tell from our study data, central blood 
volume and left ventricular mass did not differ between black and 
white subjects who were normotensive or had borderline levated 
blood pressures. Of note, patients with severe hypertension were 
excluded a priori in our study regardless of race. However, we believe 
that our relatively small data base (only 5 out 33 normotensive and 6 
out 40 borderline hypertensive subjects were African-Americans) does 
not allow us to draw any conclusions on this issue. Part of our ongoing 
efforts is to analyze the hemodynamic and structural changes occurring 
in the early development of essential hypertension a d, in particular, 
to focus on possible racial differences. Hopefully, we will be able to 
provide an answer to Gillum's question in the near future. 
FRANZ H. MESSERLI, MD, FACC, FACP 
Ochsner Clinic 
1514 Jefferson Highway 
New Orleans, Louisiana 70121 
Presentation and Attrition in Complex 
Pulmonary Atresia 
In a recent article Bull et al. (1) summarized patterns of presentation 
and attrition in complex pulmonary atresia. They conclude that 
surgical strategies in symptomatic infants have not yet demonstrated 
successful application. Recognizing that presentation i  infancy is the 
period of greatest risk, they refer to a report by Iyer and Mee (2) and 
state incorrectly that only 4 patients had their first operation i  infancy. 
The Melbourne xperience (2) cites 28 patients <2 years old entered 
into the staging programme. Of these 28 patients, 4 neonates were 
subjected to initial palliation as an emergency procedure. The remain- 
ing patients were initially stable enough to be submitted to cardiac 
catheterization a d angiography before operative intervention, i clud- 
ing one of the four emergency category patients. 
Furthermore, the Melbourne xperience (3) includes the subset of 
patients with very small pulmonary arteries. Watterson et al. (3) 
reported on 28 patients with pulmonary artresia, ventricular septal 
defect and very small pulmonary arteries and major aortopulmonary 
collateral arteries, of whom 19 underwent their first palliation at >1 
year old. Bull et al. have misread our data and have therefore drawn an 
erroneous conclusion in their discussion. 
In contrast, he data (2,3) support early intervention asthat most 
likely to succeed in achieving biventricular repair. Analysis of the 
original 58 patients (2) revealed a 78% suitability for correction in 
patients <5 years old compared with 50% for older patients. We 
hasten to add that we agree that the pattern of disease presentation is 
unlikely to be radically different in other countries. Because no infant 
was denied entry into the staged protocol on the basis of symptoms or 
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cyanosis, perhaps another hazard function for mortality in their group 
of patients might have been overlooked. 
ROGER B. B. MEE, MB, CHB, FRACS 
Department of Pediatric and Congenital Heart Surgery-M41 
The Cleveland Clinic Foundation 
9500 Euclid Avenue 
Cleveland, Ohio 44195 
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Reply 
In response to Mee, there are several issues here; the first is semantic. 
We are reprimanded for "misquoting" the number of infants in the 
series of Iyer and Mee (1). We read in their report hat "four patients 
were seen in infancy.., and underwent initial palliation as an emer- 
gency." In his letter (and in the report), Mee states that 28 patients >2 
years old entered the staging program. These statements are not in fact 
incompatible; infancy stops at a child's first birthday. In addition, Mee 
now offers us the information that four neonates were subjected to 
initial palliation as an emergency. The neonatal period stops at 1 
month of age. Even accepting that we may have misread "four 
patients" as meaning "only four patients," rereading the original report 
of Iyer and Mee does not clarify how many patients were > l  year old 
at the time of their first operation. If we have overinterpreted their 
written statement, we apologize. 
Mee also quotes fi'om another eport (2) written with coauthors 
Watterson, Wilkinson and Karl from the Royal Children's Hospital, 
Melbourne, concerning the same subject. This report (2) was accepted 
for publication earlier but was published later than the lyer and Mee 
(1) report. It included 28 patients with the same diagnosis (1980 to 
1989) defined by the nature of their primary procedure and overlap- 
ping with the 58 patients described in the Iyer and Mee report (1979 to 
1989). Oddly, cross-referencing between the two reports is minimal 
and is confined to a quote of a survival figure (the 78% suitability figure 
also quoted in the present letter), which does not in fact appear in the 
quoted report. I do not think that we can be criticized for failing to 
reconcile the numbers appearing in the two reports. Neither report 
deals with patients not undergoing operation who were seen during the 
same time frame. 
All this said, I doubt that there is any real difference in the 
arguments formulated in our and their reports, namely, that if the 
natural history of complex pulmonary atresia is to be modified, then 
intervention i the first year of life will be necessary. 
CATHERINE BULL, MD 
Great Ormond Street Hospital for Children NItS Trust 
and the Institute of Child Health 
Great Ormond Street 
London WC1N 3JH, England, United Kingdom 
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Familial Cardiomyopathy Associated With 
Right Bundle Branch Block, ST Segment 
Elevation and Sudden Death 
I read with great interest the report by Corrado et at. (1) of a case of 
familial cardiomyopathy associated with right bundle branch block 
(RBBB) and ST segment elevation. This article is a new study of 
Patient 4 previously presented by the same group (2). However, 
comparison of the two descriptions provides further information 
concerning the pathogenesis of this cardiomyopathy: 
1. There is a clear change in the pattern of ST segment elevation 
between the two reports. This confirms the recent observation of 
Brugada nd Brugada (3) of the intermittent behavior of the syndrome 
of RBBB with ST segment elevation. 
2. Electrocardiographic tracings in the present report show a 
definite (not rate dependent) PR prolongation compared with those 
tracings presented in the report by Martini et al. (striking in lead II). 
Because this young adult patient is not receiving drug therapy and 
histological analysis hows no inflammatory signs, it is probable that 
the disease process hows rapid progression. We can deduce that (at 
least in this case) fibrous tissue formation is a histologic sign of disease 
progression. Therefore, extension of fibrosis independent of lympho- 
cyte infiltrates eems to play an important role in this particular case. 
3. In addition, changes in the QRS complex with the disappear- 
ance of the R wave in leads V t to V 2 over time (unless due to electrode 
poor position) may be the result of three basic mechanisms of 
cardiomyocytes transformation: accelerated physiologic ell necrosis 
leading to fibrosis (as well as the involvement of the conduction 
system), adipose replacement assuggested by transitional forms evolving 
from cardiomyocytes to adipocytes (4). Apoptosis is the third, suggested 
but not yet proved, mechanism of cell differentiation (5). 
Corrado et al. deserve credit for presenting the first unmistakable 
demonstration of definite structural heart disease presenting with 
RBBB and intermittent ST segment elevation in the right precordial 
leads. In addition, there is a convincing explanation for the progressive 
development of an atrioventricular conduction defect involving the 
right branch with or without the presence of a parietal block. This 
demonstrates that despite the intermittent behavior of ST segment 
elevation, the original description of Brugada and Brugada is not 
always the result of a functional phenomenon. 
Nevertheless, the familial cardiomyopathy observed in this young 
male patient with a normal left ventricle demonstrating replacement of 
the right ventricular musculature by fatty tissue, surviving cardiomyo- 
cytes bordered by fibrosis, without any sign of inflammation, corre- 
sponds to the typical clinical and histologic pattern of a previously 
described form of familial cardiomyopathy called arrhythmogenic r ght 
ventricular dysplasia (6). 
GUY FONTAINE, MD, PHD, FACC 
39-41, rue Jean Le Galleu 
II?)pital Jean Rostand 
94200 Ivry'-Sur-Seine 
Paris, France 
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